JPH01247084A - Novel heat-resistant alkaline protease and production thereof - Google Patents
Novel heat-resistant alkaline protease and production thereofInfo
- Publication number
- JPH01247084A JPH01247084A JP7188788A JP7188788A JPH01247084A JP H01247084 A JPH01247084 A JP H01247084A JP 7188788 A JP7188788 A JP 7188788A JP 7188788 A JP7188788 A JP 7188788A JP H01247084 A JPH01247084 A JP H01247084A
- Authority
- JP
- Japan
- Prior art keywords
- protease
- minutes
- tyr
- nca
- bacillus stearothermophilus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 108091005658 Basic proteases Proteins 0.000 title abstract description 16
- 108091005804 Peptidases Proteins 0.000 claims abstract description 26
- 239000004365 Protease Substances 0.000 claims abstract description 25
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 25
- 241000193385 Geobacillus stearothermophilus Species 0.000 claims abstract description 9
- 238000012258 culturing Methods 0.000 claims abstract description 3
- 230000000694 effects Effects 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 12
- 239000000758 substrate Substances 0.000 claims description 10
- 108010076119 Caseins Proteins 0.000 claims description 9
- 150000001413 amino acids Chemical group 0.000 claims description 9
- 239000005018 casein Substances 0.000 claims description 9
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 9
- 235000021240 caseins Nutrition 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 6
- 239000003112 inhibitor Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 4
- 238000000862 absorption spectrum Methods 0.000 claims description 4
- MUCZHBLJLSDCSD-UHFFFAOYSA-N diisopropyl fluorophosphate Chemical compound CC(C)OP(F)(=O)OC(C)C MUCZHBLJLSDCSD-UHFFFAOYSA-N 0.000 claims description 4
- 229960005051 fluostigmine Drugs 0.000 claims description 4
- 238000002523 gelfiltration Methods 0.000 claims description 4
- 102000004877 Insulin Human genes 0.000 claims description 3
- 108090001061 Insulin Proteins 0.000 claims description 3
- 101710187199 Thermostable alkaline protease Proteins 0.000 claims description 3
- 230000002779 inactivation Effects 0.000 claims description 3
- 229940125396 insulin Drugs 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 3
- 102000009027 Albumins Human genes 0.000 claims description 2
- 108010088751 Albumins Proteins 0.000 claims description 2
- FSXRLASFHBWESK-HOTGVXAUSA-N Phe-Tyr Chemical group C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 FSXRLASFHBWESK-HOTGVXAUSA-N 0.000 claims description 2
- 108010039918 Polylysine Proteins 0.000 claims description 2
- 108010041102 azocasein Proteins 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 229920000656 polylysine Polymers 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 235000018102 proteins Nutrition 0.000 claims description 2
- 102000011632 Caseins Human genes 0.000 claims 1
- JZOYFBPIEHCDFV-YUMQZZPRSA-N Gln-His Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 JZOYFBPIEHCDFV-YUMQZZPRSA-N 0.000 claims 1
- 239000005022 packaging material Substances 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 17
- 108090000790 Enzymes Proteins 0.000 abstract description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 abstract description 4
- 235000011130 ammonium sulphate Nutrition 0.000 abstract description 4
- 239000000047 product Substances 0.000 abstract description 4
- 229910052799 carbon Inorganic materials 0.000 abstract description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 2
- 238000005342 ion exchange Methods 0.000 abstract description 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 2
- 239000002244 precipitate Substances 0.000 abstract description 2
- 230000001580 bacterial effect Effects 0.000 abstract 2
- 239000006228 supernatant Substances 0.000 abstract 1
- 239000000872 buffer Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 108090000787 Subtilisin Proteins 0.000 description 4
- 239000012228 culture supernatant Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108010047857 aspartylglycine Proteins 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 230000002797 proteolythic effect Effects 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 108010009298 lysylglutamic acid Proteins 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- LGQPPBQRUBVTIF-JBDRJPRFSA-N Ala-Ala-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LGQPPBQRUBVTIF-JBDRJPRFSA-N 0.000 description 1
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 1
- FOWHQTWRLFTELJ-FXQIFTODSA-N Ala-Asp-Met Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N FOWHQTWRLFTELJ-FXQIFTODSA-N 0.000 description 1
- LDLSENBXQNDTPB-DCAQKATOSA-N Ala-Lys-Arg Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LDLSENBXQNDTPB-DCAQKATOSA-N 0.000 description 1
- ISCYZXFOCXWUJU-KZVJFYERSA-N Ala-Thr-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(O)=O ISCYZXFOCXWUJU-KZVJFYERSA-N 0.000 description 1
- DBKNLHKEVPZVQC-LPEHRKFASA-N Arg-Ala-Pro Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(O)=O DBKNLHKEVPZVQC-LPEHRKFASA-N 0.000 description 1
- HJVGMOYJDDXLMI-AVGNSLFASA-N Arg-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCNC(N)=N HJVGMOYJDDXLMI-AVGNSLFASA-N 0.000 description 1
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 1
- WCFCYFDBMNFSPA-ACZMJKKPSA-N Asp-Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O WCFCYFDBMNFSPA-ACZMJKKPSA-N 0.000 description 1
- JHFNSBBHKSZXKB-VKHMYHEASA-N Asp-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(O)=O JHFNSBBHKSZXKB-VKHMYHEASA-N 0.000 description 1
- KPSHWSWFPUDEGF-FXQIFTODSA-N Asp-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(O)=O KPSHWSWFPUDEGF-FXQIFTODSA-N 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- XGIAHEUULGOZHH-GUBZILKMSA-N Cys-Arg-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)N XGIAHEUULGOZHH-GUBZILKMSA-N 0.000 description 1
- FAQVCWVVIYYWRR-WHFBIAKZSA-N Gln-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O FAQVCWVVIYYWRR-WHFBIAKZSA-N 0.000 description 1
- PKVWNYGXMNWJSI-CIUDSAMLSA-N Gln-Gln-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O PKVWNYGXMNWJSI-CIUDSAMLSA-N 0.000 description 1
- UQKVUFGUSVYJMQ-IRIUXVKKSA-N Gln-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCC(=O)N)N)O UQKVUFGUSVYJMQ-IRIUXVKKSA-N 0.000 description 1
- PXHABOCPJVTGEK-BQBZGAKWSA-N Glu-Gln-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O PXHABOCPJVTGEK-BQBZGAKWSA-N 0.000 description 1
- CGOHAEBMDSEKFB-FXQIFTODSA-N Glu-Glu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O CGOHAEBMDSEKFB-FXQIFTODSA-N 0.000 description 1
- BBBXWRGITSUJPB-YUMQZZPRSA-N Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O BBBXWRGITSUJPB-YUMQZZPRSA-N 0.000 description 1
- QDMVXRNLOPTPIE-WDCWCFNPSA-N Glu-Lys-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QDMVXRNLOPTPIE-WDCWCFNPSA-N 0.000 description 1
- XNOWYPDMSLSRKP-GUBZILKMSA-N Glu-Met-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(O)=O XNOWYPDMSLSRKP-GUBZILKMSA-N 0.000 description 1
- JBRBACJPBZNFMF-YUMQZZPRSA-N Gly-Ala-Lys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN JBRBACJPBZNFMF-YUMQZZPRSA-N 0.000 description 1
- QPCVIQJVRGXUSA-LURJTMIESA-N Gly-Gly-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)CNC(=O)CN QPCVIQJVRGXUSA-LURJTMIESA-N 0.000 description 1
- POJJAZJHBGXEGM-YUMQZZPRSA-N Gly-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN POJJAZJHBGXEGM-YUMQZZPRSA-N 0.000 description 1
- PNUFMLXHOLFRLD-KBPBESRZSA-N Gly-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 PNUFMLXHOLFRLD-KBPBESRZSA-N 0.000 description 1
- VPZXBVLAVMBEQI-VKHMYHEASA-N Glycyl-alanine Chemical compound OC(=O)[C@H](C)NC(=O)CN VPZXBVLAVMBEQI-VKHMYHEASA-N 0.000 description 1
- SAEWJTCJQVZQNZ-IUKAMOBKSA-N Ile-Thr-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N SAEWJTCJQVZQNZ-IUKAMOBKSA-N 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- YKNBJXOJTURHCU-DCAQKATOSA-N Leu-Asp-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YKNBJXOJTURHCU-DCAQKATOSA-N 0.000 description 1
- XGDCYUQSFDQISZ-BQBZGAKWSA-N Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O XGDCYUQSFDQISZ-BQBZGAKWSA-N 0.000 description 1
- LHSGPCFBGJHPCY-STQMWFEESA-N Leu-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-STQMWFEESA-N 0.000 description 1
- KVSBQLNBMUPADA-AVGNSLFASA-N Leu-Val-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KVSBQLNBMUPADA-AVGNSLFASA-N 0.000 description 1
- FZIJIFCXUCZHOL-CIUDSAMLSA-N Lys-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN FZIJIFCXUCZHOL-CIUDSAMLSA-N 0.000 description 1
- GQUDMNDPQTXZRV-DCAQKATOSA-N Lys-Arg-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O GQUDMNDPQTXZRV-DCAQKATOSA-N 0.000 description 1
- GJJQCBVRWDGLMQ-GUBZILKMSA-N Lys-Glu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O GJJQCBVRWDGLMQ-GUBZILKMSA-N 0.000 description 1
- PBIPLDMFHAICIP-DCAQKATOSA-N Lys-Glu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PBIPLDMFHAICIP-DCAQKATOSA-N 0.000 description 1
- NTYQUVLERIHPMU-HRCADAONSA-N Met-Phe-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N NTYQUVLERIHPMU-HRCADAONSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- LRBSWBVUCLLRLU-BZSNNMDCSA-N Phe-Leu-Lys Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(O)=O LRBSWBVUCLLRLU-BZSNNMDCSA-N 0.000 description 1
- XOHJOMKCRLHGCY-UNQGMJICSA-N Phe-Pro-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O XOHJOMKCRLHGCY-UNQGMJICSA-N 0.000 description 1
- LHALYDBUDCWMDY-CIUDSAMLSA-N Pro-Glu-Ala Chemical compound C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O LHALYDBUDCWMDY-CIUDSAMLSA-N 0.000 description 1
- ZKQOUHVVXABNDG-IUCAKERBSA-N Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 ZKQOUHVVXABNDG-IUCAKERBSA-N 0.000 description 1
- WFIVLLFYUZZWOD-RHYQMDGZSA-N Pro-Lys-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WFIVLLFYUZZWOD-RHYQMDGZSA-N 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 101710180012 Protease 7 Proteins 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241001532577 Sorangium Species 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 101150006914 TRP1 gene Proteins 0.000 description 1
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 1
- GFRIEEKFXOVPIR-RHYQMDGZSA-N Thr-Pro-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O GFRIEEKFXOVPIR-RHYQMDGZSA-N 0.000 description 1
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 1
- GFHYISDTIWZUSU-QWRGUYRKSA-N Tyr-Asn-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GFHYISDTIWZUSU-QWRGUYRKSA-N 0.000 description 1
- HPYDSVWYXXKHRD-VIFPVBQESA-N Tyr-Gly Chemical compound [O-]C(=O)CNC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 HPYDSVWYXXKHRD-VIFPVBQESA-N 0.000 description 1
- AKLNEFNQWLHIGY-QWRGUYRKSA-N Tyr-Gly-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N)O AKLNEFNQWLHIGY-QWRGUYRKSA-N 0.000 description 1
- ITDWWLTTWRRLCC-KJEVXHAQSA-N Tyr-Thr-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ITDWWLTTWRRLCC-KJEVXHAQSA-N 0.000 description 1
- UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 description 1
- LJSZPMSUYKKKCP-UBHSHLNASA-N Val-Phe-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 LJSZPMSUYKKKCP-UBHSHLNASA-N 0.000 description 1
- OWFGFHQMSBTKLX-UFYCRDLUSA-N Val-Tyr-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N OWFGFHQMSBTKLX-UFYCRDLUSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010059898 glycyl-tyrosyl-lysine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002977 hyperthermial effect Effects 0.000 description 1
- 108010012058 leucyltyrosine Proteins 0.000 description 1
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 108010035972 myxobacter alpha-lytic proteinase Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108010090894 prolylleucine Proteins 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、耐熱性アルカリ性プロテアーゼ及びその製法
に関する。さらに詳しくは、中等度高熱菌バチルス・ス
テアロサーモフィルス(Bacillusstcaro
thcrmoplti Ius)に属する菌株の培養液
上清から抽出して得られる耐熱性の高い耐熱性アルカリ
性プロテアーゼ及びその製法に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a thermostable alkaline protease and a method for producing the same. For more details, please refer to the moderately hyperthermic bacterium Bacillus stearothermophilus.
The present invention relates to a highly heat-resistant alkaline protease that is extracted from the culture supernatant of a strain belonging to P. thcrmoplti Ius, and a method for producing the same.
[従来の技術]
従来、アルカリ性プロテアーゼとしては枯草菌(13a
cillus 5ubtilis)が生産するズブチ
リシンが一般的で、また工業的にも広く利用されている
。[Prior art] Conventionally, as an alkaline protease, Bacillus subtilis (13a
Subtilisin produced by Cillus 5ubtilis is common and is also widely used industrially.
またズブチリシンの種類としては、カールスベルグ(C
arlsberg ) 、ノボ(Novo) 、 BP
N ’などが知られ、分子量20000 、活性部位残
基はAsp32番。Also, as a type of subtilisin, Carlsberg (C
arlsberg), Novo, BP
N' etc. are known, the molecular weight is 20,000, and the active site residue is Asp32.
11is 84番、 5cr221番である。またズブ
チリシン以外のアルカリ性プロテアーゼとしてはアスペ
ルギルス・オリゼー(AspergIIIus or
yzae)のアスペルギロペブチダーゼB、C,ソラン
ギウム(Soranglum )のα−リティックプロ
テアーゼおよびストレプトミセス畢グリセウス
(SLrcptomyccs grlseus )の
プロナーゼなどがある。11is No. 84, 5cr No. 221. In addition, alkaline proteases other than subtilisin include Aspergillus oryzae (AspergIIIus or
These include aspergilopebutidase B and C of S. yzae), α-lytic protease of Sorangium, and pronase of Streptomyccs grriseus (SLrcptomyccs grlseus).
これらのアルカリ性プロテアーゼは研究用試薬としての
みではなく、洗剤添加用、各種食品加工用として幅広く
使用されている。These alkaline proteases are widely used not only as research reagents but also as additives to detergents and for processing various foods.
C発明が解決しようとする課題]
このようにアルカリ性プロテアーゼは工業的にも広く利
用される蛋白質分解酵素であるが、さらに熱に対する耐
熱性が増大すれば高温での使用に耐え、使用範囲は広が
り、常温の使用においても酵素の安定性が増大する。本
発明はこれらの点に右目し、従来のアルカリ性プロテア
ーゼよりも耐熱性の高いアルカリ性プロテアーゼを提供
することを目的とするものである。[Problem to be solved by invention C] As described above, alkaline protease is a proteolytic enzyme that is widely used industrially, but if its heat resistance increases, it can withstand use at high temperatures and the range of use will expand. , the stability of the enzyme increases even when used at room temperature. The present invention takes these points into consideration and aims to provide an alkaline protease that has higher heat resistance than conventional alkaline proteases.
[課題を解決するための手段]
本発明者らは、上記課題について鋭意検討した結果、従
来のアルカリ性プロテアーゼよりも著しく耐熱性の向上
したアルカリ性プロテアーゼ(以下、プロテアーゼNG
A1503とする)を見出し、本発明に至った。[Means for Solving the Problems] As a result of intensive studies on the above problems, the present inventors have developed an alkaline protease (hereinafter referred to as Protease NG) which has significantly improved heat resistance than conventional alkaline proteases.
A1503) was discovered, leading to the present invention.
すなわち本発明は下記の酵素化学的性質を有する耐熱性
アルカリ性プロテアーゼである。That is, the present invention is a thermostable alkaline protease having the following enzymatic chemical properties.
a)分子量:約28000 (ゲル濾過法、 SDS−
PAGE)b)911安定性二37℃、30分の処理後
、pH(i〜12の範囲で90%以上の活性を有し、安
定である
C)至適pH: 10.0〜10.5
d)温度安定性二60℃、30分の熱処理後の残存活性
: 100 %
65℃、30分の熱処理後の残存活性
:50%
C)阻害剤:フェニルメチルスルホニルフルオライド(
PMSI’)
ジイソプロピルフルオロホスフェート
(DFP)
r)紫外線吸収スペクトル: 28Onm付近g)基質
特異性:カゼイン、アゾカゼイン、アルブミン、インス
リン、ポリリジン、などのタンパク質、又はペプチドに
おけるGln−111s 、 5et−111s 、
Leu−Tyr 、 Tyr−Lcu 、 Phe−T
yrの部分を特に分解する
11)アミノ酸配列及び組成:
lie Asp Pro Ala Gln Val G
lu Ala Ala VatThr Glu Lys
Thr Lys Ala lle Ilc Pro
Valllis Lcu Tyr Gly Gin M
et Ala Asp Met GluAla Ilc
Ala Ala Ile Ala Lys Arg
lll5 GlyLcu Val Val lie G
lu Asp Ala Ala Gln Alallc
Gly Ala Lys Tyr Asn Gly
Lys Cys VatGly Glu Lcu Gl
y Thr Ala Ala Thr Tyr 5er
Phc Phe Pro Thr Lys Asn L
eu Gly Ala TyrGly Asp Gly
Gly Met Ile Ile Thr Asn
AspAsp Glu Lcu Ala Glu Ly
s Cys Arg Val lieArg Val
1lis Gly Ser Lys Pro Lys
Thr ThrIt+s l1is Val Leu
Gly Thr Asn SerΔrg LcuAsp
Glu Met Gln Ala Ala lle
Leu Ser ValLys Phc Pro l1
ls Leu Asp Arg Trp Thr Gl
uGln Arg Arg Lys lll5 Ala
Ala Thr Tyr ThrArg Lcu L
eu Glu Glu Ala Asp Gly As
p LeuVal Val Thr Pro Lys
Glu Vat Asp Gly ArgTl+r l
ll5 Val Plte lll5 Gln Tyr
Thr lle ArgAla Pro Lys
Arg Asp Glu Lcu Gln
Ala PheLeu Lys Glu
Gln Gly Ilc Ala Thr
Met ValTyr Tyr Pro Lc
u Pro Leu l1is Lcu G
in Pr。a) Molecular weight: approximately 28,000 (gel filtration method, SDS-
PAGE) b) 911 Stability After treatment at 37°C for 30 minutes, pH (has 90% or more activity in the range of i to 12 and is stable) Optimum pH: 10.0 to 10.5 d) Temperature stability - Residual activity after heat treatment at 60°C for 30 minutes: 100% Residual activity after heat treatment at 65°C for 30 minutes: 50% C) Inhibitor: Phenylmethylsulfonyl fluoride (
PMSI') Diisopropyl fluorophosphate (DFP) r) Ultraviolet absorption spectrum: around 28 Onm g) Substrate specificity: Gln-111s, 5et-111s, in proteins or peptides such as casein, azocasein, albumin, insulin, polylysine, etc.
Leu-Tyr, Tyr-Lcu, Phe-T
11) Amino acid sequence and composition that specifically resolves the yr portion: lie Asp Pro Ala Gln Val G
lu Ala Ala VatThr Glu Lys
Thr Lys Ala lle Ilc Pro
Vallis Lcu Tyr Gly Gin M
et Ala Asp Met GluAla Ilc
Ala Ala Ile Ala Lys Arg
ll5 GlyLcu Val Val lie G
lu Asp Ala Ala Gln Allalc
Gly Ala Lys Tyr Asn Gly
Lys Cys VatGly Glu Lcu Gl
y Thr Ala Ala Thr Tyr 5er
Phc Phe Pro Thr Lys Asn L
eu Gly Ala TyrGly Asp Gly
Gly Met Ile Thr Asn
AspAsp Glu Lcu Ala Glu Ly
s Cys Arg Val lieArg Val
1lis Gly Ser Lys Pro Lys
Thr ThrIt+s l1is Val Leu
Gly Thr Asn SerΔrg LcuAsp
Glu Met Gln Ala Ala lle
Leu Ser ValLys Phc Pro l1
ls Leu Asp Arg Trp Thr Gl
uGln Arg Arg Lys lll5 Ala
Ala Thr Tyr Thr Arg Lcu L
eu Glu Glu Ala Asp Gly As
p LeuVal Val Thr Pro Lys
Glu Vat Asp Gly ArgTl+r l
ll5 Val Plte ll5 Gln Tyr
Thr lle ArgAla Pro Lys
Arg Asp Glu Lcu Gln
Ala PheLeu Lys Glu
Gln Gly Ilc Ala Thr
Met ValTyr Tyr Pro Lc
u Pro Leu l1is Lcu G
in Pr.
Val Phe Ala Sar Lcu
Gly Tyr Lys Glu GlyGl
n Lcu Pro Glu Ala Gl
u Lys Ala Ala LysGlu
Ala I、cu Ser Leu Pro
Met Phe Pro GluLcu
Lys Glu Glu Gln Gln
Gln Tyr Val VatGlu Lys
IIeAla Glu Phc Tyr Arg 1
lis Phcla
のアミノ酸261個からなる
アミノ酸組成
Ala 32. Arg 12. Asp12 、 A
sn 4 、 Cys 2 。Val Phe Ala Sar Lcu
Gly Tyr Lys Glu GlyGl
n Lcu Pro Glu Ala Gl
u Lys Ala Ala LysGlu
Ala I, cu Ser Leu Pro
Met Phe Pro GluLcu
Lys Glu Glu Gln Gln
Gln Tyr Val Vat Glu Lys
IIeAla Glu Phc Tyr Arg 1
Amino acid composition of lis Phcla consisting of 261 amino acids Ala 32. Arg 12. Asp12, A
sn4, Cys2.
Gln 13. Glu 23. Gly 17. l
1is 11. ll014゜Lcu 22. I、y
s 19. Met O、Phe 9 、 Pro 1
3゜Ser G 、 Thr 12. Trp 1 、
Tyr15 、 Vai 181)構造遺伝子の塩基
配列
ATCGATCCAGCGCAAGTTGAAGCGG
CGGTGACGGAGAAGATAGCTAGGTC
GCGTTCAACTTCGCCGCCACTGCCT
CTTCTCGAAAGCCATCATCCCGGTG
CATTTGTACGGGCAAATGGCGCTTT
CGGTAGTAGGGCCACGTAAACATGC
CCGTTTACCG<← く← ロロ ←< 0■
<← ロロ ロロ ロロ く←
■ロ ロロ ロロ ロ0 <←
口■ ロロ ロロ ロ0 ロ■
0ロ ロロ く← Oロ ■O
く← ロロ ロロ (← ■ロ
ロロ ロロ ロロ ロQ <←
■ロ ロロ ロロ 0ロ ←く
口■ ロロ E−1<<← ←く
OC:5 ロロ ←く ロロ く←
ロロ ロロ ロロ ロロ ■ロ
ロロ <← ロロ ○ロ ←く
<← <!−1<← ←く ←く
ロロ ロロ <← ロC:5<←
■ロ ←< <← ←く ■ロ
ロロ ←く ロロ ←<00
口Q <← ロロ ←く ロ○
く← ロロ ロロ ロ○ ■0
←< ←< <← く← ←く
く← ←く ロロ ←く く←
口■ ←く く← (jQ ロQ
く← く← (j C) C:5Q<←<1−Il−
1<<← ロOl−1<
■Oく← く← ←く く←
■ロ ロ■ ロ■ く← ロ○
GTTGTGACGCCGAAAGAAGTCGACG
GTCGCTATCATGTGTCAAC八CTGCG
GCTTTCTTCAGCTGCCAGCGATAGT
ACACATCCATCAATACACGATTCGA
GCGCCG八AGCGCGACGAGTTAGGT八
GTTATGTGCTA八GCTCGCGGCTTCG
CGCTGCTCAAGCAAGCGTTTTTGAA
AGAACAGGCGATCGCGACGATGGTG
CGTTCGCAAAAACTTTCTTGTCCCC
TAGCGCTGCTACCACTACTATCCGC
TGCCGCTGCATTTGCAGCCGGTGTT
TGCTTATGATAGGCGACGGCGACGT
AAACGTCGGCCACAAACGAACGCTC
GGGTATAAGGAAGGGCAGTTGCCGG
AGGCGGAAΔAGCGAGCCCATATTCC
TTCCCGTCAACGGCCTCCGCCTTTT
AGCGGCGAAAGAAGCGCTGTCGCTG
CCGATGTTCCC八GΔGTCGCCGCTTT
CTTCGCGACAGCGACGGCTACAAGG
GTCTCCTGAAAGAGGAGCAGCAACA
GTACGTCGTCGAGAAAATCGGACTT
TCTCCTCGTCGTTGTCATGCAGCAG
CTCTTTTAGCCGGAATTTTACCGTC
ATTTCGCTGCCTTAAAATGGCAGTA
八AGCGAの783塩基対からなる
pl+及び温度による失活の条件二
pl14.0 . 37℃,30分間で約50%が失活
する。さらにpllIO. 70℃,30分間でほぼ完
全に失活する。Gln 13. Glu 23. Gly 17. l
1is 11. ll014°Lcu 22. I,y
s19. Met O, Phe 9, Pro 1
3゜Ser G, Thr 12. Trp 1,
Tyr15, Vai 181) Structural gene base sequence ATCGATCCAGCGCAAGTTGAAGCGG
CGGTGACGGAGAAGATAGCTAGGTC
GCGTTCAACTTCGCCGCCACTGCCT
CTTCTCGAAAGCCATCATCCCCGGTG
CATTTGTACGGGCAAATGGCGCTTT
CGGTAGTAGGGCCACGTAAAACATGC
CCGTTTACCG<← く← Roro ←< 0■ <← Roro Roro Roro KU← ■Ro Roro Roro Ro0 <← Mouth■ Roro Rolo Ro0 Ro■ 0ro Roro Ku← Oro ■O Ku← Roro Roro (← ■Rororo Lolo Lolo Lolo Q <← ■Ro Rolo Lolo 0ro ← Kuguchi■ Rolo E-1<<← ←ku OC: 5 Rolo ←ku Rolo Ku← Rolo Rolo Rolo Lolo ■Rororo <← Roro ○Ro ←ku<← < !-1<← ←ku ←ku Roro Roro <← RoC: 5<← ■Ro ←< <← ←ku ■Rororo ←ku Roro ←<00 Mouth Q <← Roro ←ku Ro○ Ku← Roro Roro Ro○ ■0 ←< ←< <← Ku← ←Kuku← ←KU Roro ←Ku Ku← Mouth■ ←Ku Ku← (jQ ROQ Ku← Ku← (j C) C:5Q<←<1−Il−
1<<← RoOl-1< ■Oku← Ku← ←ku Ku← ■Ro Ro■ Ro■ Ku← Ro○ GTTGTGACGCCGAAAGAAGTCGACG
GTCGCTATCATGTGTCAAC8CTGCG
GCTTTCTTCAGCTGCCAGCGATAGT
ACACATCCATCAATACACGATTCGA
GCGCCG8AGCGCGACGAGTTAGGT8GTTATGTGCTA8GCTCGCGGCTTCG
CGCTGCTCAAGCAAGCGTTTTTGAA
AGAACAGGCGATCGCGACGATGGTG
CGTTCGCAAAAAAACTTTCTTGTCCCCC
TAGCGCTGCTACCACTACTATCCGC
TGCCGCTGCATTTGCAGCCGGTGTT
TGCTTATGATAGGCGACGGCGACGT
AAACGTCGGCCACAAAACGAACGCTC
GGGTATAAGGAAGGGGCAGTTGCCGG
AGGCGGAAΔAGCGAGCCCATATTCC
TTCCCGTCAACGGCCTCCGCCTTT
AGCGGCGAAAGAAGCGCTGTCGCTG
CCGATGTTCCC8GΔGTCGCCGCTTT
CTTCGCGACAGCGACGGCTACAAGG
GTCTCCTGAAAGAGGAGCAGCAACA
GTACGTCGTCGAGAAAATCGGACTT
TCTCCTCGTCGTTGTCATGCAGCAG
CTCTTTTAGCCGGAATTTTACCGTC
ATTTCGCTGCCTTAAAATGGCAGTA
pl+ consisting of 783 base pairs of 8 AGCGA and temperature-induced inactivation conditions 2 pl14.0. Approximately 50% of the activity is lost in 30 minutes at 37°C. Furthermore, pllIO. It is almost completely inactivated at 70°C for 30 minutes.
また本発明は、耐熱性アルカリ性プロテアーゼの製法に
関するものであり、バチルス・ステアロサーモフィルス
(Bacillus stcarothcrmoph
l!us)属に属し、プロテアーゼNCA 1 5 0
3を生産する細菌を培養し、培養上清からプロテアー
ゼNCAl503を採取することを特徴とするプロテア
ーゼNCAl503の製造方法に関する。The present invention also relates to a method for producing a heat-stable alkaline protease, and relates to a method for producing a heat-stable alkaline protease.
l! protease NCA 1 5 0
The present invention relates to a method for producing protease NCAl503, which comprises culturing bacteria that produce 3 and collecting protease NCAl503 from the culture supernatant.
本発明で使用されるプロテアーゼNCAl503生産微
生物は、プロテアーゼNCAl5Q3を生産することの
できるバチルス・ステアロサーモフィルス(Bacil
lus stearothermophllus)属
に属する全ての菌株、突然変異株、および変種を包含す
る。中でも特に好ましい菌株は、バチルス中ステア口サ
ーモフィルスNCA1503 (Bacillusst
earotherIIlophilus NCAl50
3) (微工研菌寄第8978号)である。The protease NCAl503-producing microorganism used in the present invention is Bacillus stearothermophilus (Bacillus stearothermophilus) capable of producing protease NCAl5Q3.
It includes all strains, mutants, and variants belonging to the genus S. lus stearothermophllus. Among them, a particularly preferable strain is Bacillus stairmouth thermophilus NCA1503.
earthher IIlophilus NCAl50
3) (Feikoken Bibori No. 8978).
本発明のプロテアーゼNCA1503を生産するには、
例えば、上記のバチルス・ステアロサーモフィルス N
C1503 (Bacillus staaroth
ermophIIus NCAJ503)を炭素源、窒
素源、塩類、その他の物質を含有する培地に摂取し、適
当な温度、例えば約50〜60℃で酵素力価が最高に達
するまでの適当な時間、好気的条件下、例えば、振とう
または通気撹拌培養して生産する方法がある。To produce the protease NCA1503 of the present invention,
For example, the above Bacillus stearothermophilus N
C1503 (Bacillus staroth)
ermoph IIus NCAJ503) in a medium containing a carbon source, nitrogen source, salts, and other substances, and aerobically maintained at an appropriate temperature, e.g., about 50 to 60°C, for an appropriate period of time until the enzyme titer reaches its maximum. There are methods of production under various conditions, for example, shaking or aerated agitation culture.
上記のようにして培養された培養物は、遠心分離、濾過
などの方法で清澄にした後、この清澄液に例えば硫酸ア
ンモニウムを加えて目的の酵素を沈澱させ、採取するこ
とができる。またさらにイオン交換法、ゲル濾過法を利
用して上記沈澱物をさらに精製して、極めて高いプロテ
アーゼNCAl503を得ることもできる。After the culture cultured as described above is clarified by a method such as centrifugation or filtration, the enzyme of interest can be collected by adding, for example, ammonium sulfate to the clarified solution. Furthermore, the above precipitate can be further purified using an ion exchange method or a gel filtration method to obtain extremely high protease NCAl503.
このようにして得られた新規のプロテアーゼNCA15
03の理化学的性質を以下に示す。The novel protease NCA15 obtained in this way
The physical and chemical properties of 03 are shown below.
(1)作用
カゼインを基質として使用した37℃での蛋白質分解作
用の好適pllは、図1に示すごと< 、pnq〜l1
であり、至適pl[Lo〜19.5のアルカリ性プロテ
アーゼである。(1) Action The preferred pll for proteolytic action at 37°C using casein as a substrate is <, pnq~l1 as shown in Figure 1.
and is an alkaline protease with an optimal pl[Lo~19.5.
(2)基質特異性
37℃, pl18.5でB鎖を基質として分解させた
ところ図2に示すごと< Ciln−111s , S
er−I11s , Lcu−Tyr , Tyr−L
eu , Phe−Tyrの部分を分解する。(2) Substrate specificity When the B chain was degraded as a substrate at 37°C and pl18.5, as shown in Figure 2, < Ciln-111s, S
er-I11s, Lcu-Tyr, Tyr-L
Decompose the eu and Phe-Tyr parts.
(3)至適[)I1
カゼインを基質として使用した37℃での蛋白質分解作
用における11+1の影響を図1に示す。至適pllは
lO〜10,5である。(3) Optimal [)I1 The influence of 11+1 on the proteolytic action at 37° C. using casein as a substrate is shown in FIG. The optimal pll is lO~10,5.
(4)pll安定性
カゼインを基質として各種pl+で37℃,30分の処
理後の残存活性を図3に示す。pH6〜l2の範囲で9
0%以上の残存活性を示した。またpl+4.0では約
50%が失活した。(4) pll stability Figure 3 shows the residual activity after treatment with various pl+ at 37°C for 30 minutes using casein as a substrate. 9 in the pH range of 6-12
It showed residual activity of 0% or more. Moreover, at pl+4.0, about 50% was inactivated.
(5)力価の測定法
1 mlの2%カゼイン溶液( 50mM }リスー塩
酸,pl18.5 )に1 mlの各試料を加え、一定
時間後に反応停止液( 0.33M酢酸, 0.22M
酢酸ナトリウム,0.1M}リクロ口酢酸)を2ml加
え、室温で30分間放置した。これをワットマンNO−
1濾紙で;点過した。これとは別に、カゼイン溶液に
反応停止液をいれ、試料を加え、濾過したものを基準と
してA nmをilPI定し、千ロシン溶液を基僧
としたA の検量線を作成してプロテアーゼ活性を4
Dj定した。IIi位は37℃で1分間に1μgのチロ
シン相当物質をトリクロロ酢酸可溶性区分に遊離させる
酵素量とした。(5) Method for measuring titer Add 1 ml of each sample to 1 ml of 2% casein solution (50mM Li-HCl, pl18.5), and after a certain period of time add reaction stop solution (0.33M acetic acid, 0.22M)
2 ml of sodium acetate, 0.1 M}lichloroacetic acid) was added, and the mixture was allowed to stand at room temperature for 30 minutes. Whatman NO-
1 filter paper; Separately, a reaction stop solution was added to the casein solution, a sample was added, and the filtered sample was used as a standard to determine A nm using ilPI, and a calibration curve for A was created using the 1,000 rosin solution as the base to determine the protease activity. 4
Dj was established. Position IIi was the amount of enzyme that released 1 μg of a substance equivalent to tyrosine into the trichloroacetic acid soluble fraction per minute at 37°C.
(6)至適温度
カゼインを基質として使用したpl+8.5での蛋白質
分解作用の温度依存性を図4に示す。本酵素の作用最適
温度は約55℃にある。(6) Optimal temperature The temperature dependence of proteolytic action at pl+8.5 using casein as a substrate is shown in FIG. The optimum temperature for the action of this enzyme is approximately 55°C.
(7)温度安定性
カゼインを基質としてpl+8.5での温度安定性を図
5に示す。本酵素は60℃、30分熱処理後の残存活性
は100%と、アルカリ性プロテアーゼとしては非常に
安定である。また65°C130分の熱処理後の残存活
性は50%である。70℃、30分の熱処理でほぼ完全
に失活する。(7) Temperature stability Figure 5 shows the temperature stability at pl+8.5 using casein as a substrate. This enzyme has a residual activity of 100% after heat treatment at 60°C for 30 minutes, making it extremely stable as an alkaline protease. The residual activity after heat treatment at 65° C. for 130 minutes is 50%. It is almost completely inactivated by heat treatment at 70°C for 30 minutes.
(8)阻害剤の影響 阻害剤の影響を表1に示す。(8) Effect of inhibitors The effects of inhibitors are shown in Table 1.
表1 阻害剤の影響
EDTA :エチレンジアミン4酢酸
PMSF:フェニルメチルスルホニルフルオライドop
p ニジイソプロピルフルオロホスフェート(9)プロ
テアーゼの精製方法
培養上清から硫安沈澱、透析などして得た粗酵素サンプ
ルは、例えば次の方法で分離精製することができる。す
なわち粗酵素サンプル約1gをlOm+の0.1Mリン
酸緩衝液pH8,0に溶解し、同緩衝液で弔衡化した。Table 1 Effect of inhibitors EDTA: ethylenediaminetetraacetic acid PMSF: phenylmethylsulfonyl fluoride op
Method for purifying p Nidiisopropylfluorophosphate (9) protease A crude enzyme sample obtained from the culture supernatant by ammonium sulfate precipitation, dialysis, etc. can be separated and purified, for example, by the following method. That is, about 1 g of the crude enzyme sample was dissolved in lOm+ 0.1M phosphate buffer pH 8.0 and equilibrated with the same buffer.
Toyopearl−IIW50 (商品名、東ソー■
製)を充填したカラム(1,5X80cm)上部に静か
に流し込み、同緩衝液で溶出する。ここで得た活性画分
をさらにTS’Kgel−G2000SW (商品名、
東ソー沖製)にかけ、ピークフラクションを分取する。Toyopearl-IIW50 (Product name, Tosoh ■
Pour the solution gently onto the top of a column (1.5 x 80 cm) packed with 1.5 x 80 cm, and elute with the same buffer. The active fraction obtained here was further added to TS'Kgel-G2000SW (trade name,
(manufactured by Tosoh Oki) and collect the peak fraction.
活性画分は硫酸アンモニウム塩析(70%飽和)もしく
は限外濾過膜(UP−10PS 、商品名、東ソー■製
)などを用い濃縮し、透析した後、凍結乾燥する。The active fraction is concentrated using ammonium sulfate salting out (70% saturation) or an ultrafiltration membrane (UP-10PS, trade name, manufactured by Tosoh Corporation), dialyzed, and then freeze-dried.
(10)分子量
ゲル濾過法、 SDS−ポリアクリルアミドゲル電気泳
動法により測定した分子量は約28000 、アミノ酸
配列からの分子量は294f30である。(10) Molecular weight The molecular weight measured by gel filtration method and SDS-polyacrylamide gel electrophoresis method is about 28,000, and the molecular weight from the amino acid sequence is 294f30.
(11)紫外線吸収スペクトル
図6に示すごとく、吸収極大は約280 nm付近にあ
り、吸収極小は約245〜255nmにある。(11) Ultraviolet absorption spectrum As shown in Figure 6, the absorption maximum is around 280 nm and the absorption minimum is around 245-255 nm.
(12)アミノ酸組成
[発明が解決しようとする課題]の欄h)アミノ酸配列
及び組成に示ずごと<261個のアミノ酸からなる。(12) Amino acid composition [Problem to be solved by the invention] Column h) Amino acid sequence and composition are not shown < Consisting of 261 amino acids.
(13)塩基配列
[発明が解決しようとする課題]の欄■)構造遺伝子の
塩基配列に示すごと<、783塩基対からなる。(13) Base sequence [Problem to be solved by the invention] column ■) As shown in Base sequence of structural gene, it consists of 783 base pairs.
[発明の効果]
本発明によるプロテアーゼNCAl3O3は、従来のア
ルカリ性プロテアーゼよりも耐熱性が高く、高温での使
用に耐え、使用範囲は広がり、常温の使用においても酵
素の安定性が増大する。またプロテアーゼNCAl3O
3は、本発明方法により得ることができる。[Effects of the Invention] The protease NCAl3O3 according to the present invention has higher heat resistance than conventional alkaline proteases, can withstand use at high temperatures, has a wider range of use, and has increased enzyme stability even when used at room temperature. Also protease NCAl3O
3 can be obtained by the method of the present invention.
[実施例コ
次に実施例を示す。しかし本発明はこれら実施例のみに
限定されるものではない。[Example] Next, an example will be shown. However, the present invention is not limited to these examples.
(実施例1)
表2 培地成分
表2に示す組成の培地500 mlを2.i2容の坂ロ
フラスコに入れ、120℃、 15分滅菌する。同組成
の培地で培養したバチルス・ステアロサーモフィルス
NCAl3O3の前培ヱを液5 mlを加え、50℃、
150rpm。(Example 1) Table 2 Medium composition 500 ml of a medium having the composition shown in Table 2 was mixed with 2. Place in a 2 volume Sakaro flask and sterilize at 120°C for 15 minutes. Bacillus stearothermophilus cultured in a medium with the same composition
Add 5 ml of NCAl3O3 preculture and incubate at 50°C.
150rpm.
24時間振とう培養した。この培養上清を硫酸アンモニ
ウムを7026飽和になるように加え、酵素活性画分を
析出させたのち、遠心分離(1l10000rp 。Culture was carried out with shaking for 24 hours. Ammonium sulfate was added to the culture supernatant to saturation of 7,026 ml to precipitate the enzyme active fraction, followed by centrifugation (1 l, 10,000 rpm).
10分)して集めた。集めた酵素をできるだけ少量の0
.1Mリン酸緩衝液1)118.0に懸濁し、透析チュ
ーブにつめ24時間、4℃で透析した。透析後、不溶物
を遠心分離して除き、凍結乾燥し、得られた粉末を粗酵
素サンプルとした。粗酵素サンプル約1gを10m1の
061Mリン酸′ijU衝液pH8,0に溶解し、同緩
衝液で平衡化した。Toyopearl−11W50
(商品名。10 minutes) and collected. Collect the collected enzymes into as little amount as possible.
.. The suspension was suspended in 1M phosphate buffer 1) 118.0, packed in a dialysis tube, and dialyzed at 4°C for 24 hours. After dialysis, insoluble matter was removed by centrifugation and freeze-dried, and the resulting powder was used as a crude enzyme sample. Approximately 1 g of the crude enzyme sample was dissolved in 10 ml of 061M phosphate 'ijU buffer, pH 8.0, and equilibrated with the same buffer. Toyopearl-11W50
(Product name.
東ソー■製)を充填したカラム(L、5 X80cm)
上部に静かに流し込み、同緩衝液で溶出した。ここで得
た活性画分をさらにTSKgcl−G2000SW (
商品名。Column (L, 5 x 80cm) packed with Tosoh Co., Ltd.)
It was poured gently into the upper part and eluted with the same buffer. The active fraction obtained here was further added to TSKgcl-G2000SW (
Product name.
東ソー■製)にかけ、ピークフラクションを分取した。(manufactured by Tosoh ■) and the peak fraction was collected.
活性画分を限外濾過膜(UF−10Ps 、商品名。The active fraction was filtered through an ultrafiltration membrane (UF-10Ps, trade name).
東ソー■製)を用い濃縮し、透析した後、凍結乾燥した
。11の培養液から0.05gのプロテアーゼNCAl
3O3を得た。After concentrating and dialysing using Tosoh Corporation (trade name), it was freeze-dried. 0.05 g of protease NCAl from culture broth of 11
3O3 was obtained.
精製した酵素の純度はポリアクリルアミドゲル電気泳動
(12,5%)及び高速液体クロマトグラフィー(カラ
ムTSKgel G2000SW)で分析した結果、い
ずれの場合も単一のタンパク質バンドが検出できた。The purity of the purified enzyme was analyzed by polyacrylamide gel electrophoresis (12.5%) and high performance liquid chromatography (column TSKgel G2000SW), and a single protein band was detected in both cases.
(実施例2)
洗剤などに用いられているズブチリシン・カルスベルブ
とプロテアーゼNCA 1503のアルカリ溶液中(は
う酸−水酸化ナトリウム緩衝液、pi19.O)におい
て各温度における酵素活性の半減時間のδ1す定を行っ
た。結果を表3に示す。(Example 2) Half-life time δ1 of enzyme activity at each temperature in an alkaline solution of subtilisin callsuberub used in detergents and protease NCA 1503 (halal acid-sodium hydroxide buffer, pi19.O) I made a decision. The results are shown in Table 3.
表3
このように従来工業的に使用されているズブチリシン・
カールスベルグと比べてアルカリ溶液中においてプロテ
アーゼNCΔ1503は60℃まではとんと失t1−シ
ない。Table 3 As shown above, subtilisin and
Compared to Carlsberg, protease NCΔ1503 does not lose much t1 in alkaline solution up to 60°C.
図1はプロテアーゼNCAl3O3の至適pl+を示す
図である。
図2はプロテアーゼNCAl3O3の酸化インスリンB
鎖の分解を示し、この酵素の基質特異性を示す図である
。
図3はプロテアーゼNOΔ1503のpH安定性を示す
図である。
図4はプロテアーゼNCAl3O3の至適温度を示す図
である。
図5はプロテアーゼNCAL503の温度安定性を示す
図である。
図6はプロテアーゼNCAl3O3の水溶液中での紫外
線吸収スペクトルを示す図である。
特許出願人 東ソー株式会ト土
8.0 9.0 10.0 11.0図
□温度じC)
図5
一時間(分)FIG. 1 is a diagram showing the optimal pl+ of protease NCAl3O3. Figure 2 shows oxidized insulin B of protease NCAl3O3.
FIG. 3 shows chain degradation and demonstrates the substrate specificity of this enzyme. FIG. 3 is a diagram showing the pH stability of protease NOΔ1503. FIG. 4 is a diagram showing the optimum temperature of protease NCAl3O3. FIG. 5 is a diagram showing the temperature stability of protease NCAL503. FIG. 6 is a diagram showing the ultraviolet absorption spectrum of protease NCAl3O3 in an aqueous solution. Patent applicant: Tosoh Corporation 8.0 9.0 10.0 11.0 Figure □ Temperature C) Figure 5 One hour (minute)
Claims (3)
プロテアーゼ。 分子量:約28000(ゲル濾過法、SDS−PAGE
)pH安定性:37℃、30分の処理後、pH6〜12
の範囲で90%以上の活性を有し、安定である 至適pH:10.0〜10.5 温度安定性:60℃、30分の熱処理後の残存活性:1
00% 65℃、30分の熱処理後の残存活性:50% 阻害剤:フェニルメチルスルホニルフルオライド(PM
SF) ジイソプロピルフルオロホスフェート(DFP) 紫外線吸収スペクトル:280nm付近 基質特異性:カゼイン、アゾカゼイン、アルブミン、イ
ンスリン、ポリリジン、などのタンパク質、又はペプチ
ドにおけるGln−His、Sor−His、Leu−
Tyr、Tyr−Lou、Phe−Tyrの部分を特に
分解する アミノ酸配列及び組成: 【遺伝子配列があります。】 のアミノ酸261個からなる アミノ酸組成 【遺伝子配列があります。】 構造遺伝子の塩基配列 【遺伝子配列があります。】 の783塩基対からなる pH及び温度による失活の条件: pH4.0、37℃、30分間で約50%が失活する。 さらにpH10、70℃、30分間でほぼ完全に失活す
る。(1) A thermostable alkaline protease having the following enzymatic chemical properties. Molecular weight: approximately 28,000 (gel filtration method, SDS-PAGE
) pH stability: pH 6-12 after treatment at 37°C for 30 minutes
Optimal pH: 10.0-10.5 Temperature stability: Residual activity after heat treatment at 60°C for 30 minutes: 1
00% Residual activity after heat treatment at 65°C for 30 minutes: 50% Inhibitor: Phenylmethylsulfonyl fluoride (PM
SF) Diisopropyl fluorophosphate (DFP) Ultraviolet absorption spectrum: around 280 nm Substrate specificity: Gln-His, Sor-His, Leu- in proteins such as casein, azocasein, albumin, insulin, polylysine, or peptides
Amino acid sequence and composition that specifically breaks down Tyr, Tyr-Lou, and Phe-Tyr parts: [There is a gene sequence. ] Amino acid composition consisting of 261 amino acids [There is a gene sequence. ] Structural gene base sequence [There is a gene sequence. Conditions for pH and temperature inactivation: pH 4.0, 37°C, approximately 50% inactivation in 30 minutes. Furthermore, it is almost completely inactivated at pH 10, 70° C., and 30 minutes.
hilus¥)に属する菌株を培養して、該培養液より
特許請求の範囲第1項記載のプロテアーゼを採取するこ
とを特徴とするプロテアーゼの製法。(2) Bacillus stearothermop
1. A method for producing a protease, which comprises culturing a strain belonging to P. hilus and collecting the protease according to claim 1 from the culture solution.
1503(¥Bacillus¥¥stearothe
rmophilus¥NCA1503)(微工研菌寄第
8978号)である特許請求の範囲第2項記載の方法。(3) The strain is Bacillus stearothermophilus NCA
1503(¥Bacillus¥¥stearothe
rmophilus¥NCA1503) (Feikoken Bibori No. 8978).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63071887A JP2643264B2 (en) | 1988-03-28 | 1988-03-28 | New thermostable alkaline protease and its manufacturing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63071887A JP2643264B2 (en) | 1988-03-28 | 1988-03-28 | New thermostable alkaline protease and its manufacturing method |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01247084A true JPH01247084A (en) | 1989-10-02 |
JP2643264B2 JP2643264B2 (en) | 1997-08-20 |
Family
ID=13473495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63071887A Expired - Lifetime JP2643264B2 (en) | 1988-03-28 | 1988-03-28 | New thermostable alkaline protease and its manufacturing method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2643264B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06181760A (en) * | 1992-12-22 | 1994-07-05 | Kao Corp | Alkaliprotease k-16h |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58162291A (en) * | 1982-03-23 | 1983-09-26 | Res Dev Corp Of Japan | Preparation of heat-resistant protease |
-
1988
- 1988-03-28 JP JP63071887A patent/JP2643264B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58162291A (en) * | 1982-03-23 | 1983-09-26 | Res Dev Corp Of Japan | Preparation of heat-resistant protease |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06181760A (en) * | 1992-12-22 | 1994-07-05 | Kao Corp | Alkaliprotease k-16h |
Also Published As
Publication number | Publication date |
---|---|
JP2643264B2 (en) | 1997-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ebeling et al. | Proteinase K from Tritirachium album limber | |
Kim et al. | Purification and characterization of a fibrinolytic enzyme produced from Bacillus sp. strain CK 11-4 screened from Chungkook-Jang | |
US5304723A (en) | Biologically pure culture of maltopentaose forming amylase producing alkalophilic bacteria | |
AU632002B2 (en) | A novel protease | |
US3871963A (en) | Microbial protease and preparation thereof | |
US5192677A (en) | Alkali and heat stable protease from thermomonospora fusca | |
Sakiyama et al. | [9] Lysyl endopeptidase of Achromobacter lyticus | |
JPH05992B2 (en) | ||
JPH01247084A (en) | Novel heat-resistant alkaline protease and production thereof | |
JP2882652B2 (en) | Alkaline protease and its producing microorganism | |
JP3685814B2 (en) | Aminopeptidase and production method thereof | |
Cheng et al. | Purification and some properties of an aminopeptidase from Bifidobacterium breve | |
JP2676453B2 (en) | Alkaline isoamylase, microorganism producing the same, and method for producing the alkaline isoamylase | |
KR100227314B1 (en) | Novel aminopeptidase and bacillus strain producing therefor | |
JP2560334B2 (en) | Novel heat-resistant neutral protease and method for producing the same | |
JP4485734B2 (en) | 5-substituted hydantoin racemase, DNA encoding the same, recombinant DNA, transformed cell, and method for producing optically active amino acid | |
EP0579710B1 (en) | Novel proteases from dendryphiella | |
JPS6123994B2 (en) | ||
JP2873936B2 (en) | Cold-active protease and its production | |
JP3358686B2 (en) | Gene encoding novel glutamate dehydrogenase and method for producing glutamate dehydrogenase using the gene | |
JP3026111B2 (en) | Novel alkaline protease and method for producing the same | |
JP2985018B2 (en) | New microorganism | |
JP3516318B2 (en) | Novel endopeptidase | |
KR100243526B1 (en) | An aminopeptidase purified from aspergillus flavus and a method removing methionine residue from recombinant | |
JPH034789A (en) | Novel halophilic protease and its production |